Pune, Feb. 09, 2024 (GLOBE NEWSWIRE) -- According to the latest report published by Growth Plus Reports, the global Apheresis Equipment Market is expected to clock US$ 6.57 billion by 2031 and to grow at a CAGR of 9.8% during the forecast period.
The global Apheresis Equipment Market is experiencing substantial growth, driven by the increasing prevalence of chronic and autoimmune diseases, rising demand for blood components and plasma-derived therapies, and technological advancements in apheresis technology. A comprehensive analysis of the market reveals a dynamic landscape dedicated to enhancing therapeutic plasma exchange and blood component collection for various medical conditions.
Get a Sample Copy of the Research Report: https://www.growthplusreports.com/inquiry/request-sample/apheresis-equipment-market/8509
Apheresis Equipment Market Scope
| Report Attribute | Details |
| Market Size Value in 2022 | US$ 2.83 billion |
| Revenue Forecast in 2031 | US$ 6.57 billion |
| Growth Rate | 9.8% |
| Base Year for Estimation | 2022 |
| Forecast Period | 2023-2031 |
| Historical Year | 2021 |
| Segments Covered | Product, Procedure, Technology, Application, and Region |
| Regional Scope | North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
Market Overview:
Apheresis equipment refers to medical devices used for therapeutic plasma exchange, red blood cell depletion, plateletpheresis, leukapheresis, and other extracorporeal blood purification procedures. The Apheresis Equipment Market encompasses a wide range of devices, including centrifugal apheresis systems, membrane-based apheresis systems, and automated collection devices, designed to efficiently separate blood components and perform therapeutic procedures in clinical settings.
Key Market Drivers:
- Rising Demand for Blood Components and Plasma-Derived Therapies: The growing prevalence of hematological disorders, autoimmune diseases, and solid organ transplantation drives the demand for blood components and plasma-derived therapies. Apheresis technology enables the selective collection of specific blood components, such as platelets, plasma, and white blood cells, for therapeutic purposes, addressing the diverse medical needs of patients.
- Technological Advancements in Apheresis Systems: Ongoing advancements in apheresis technology enhance device performance, automation capabilities, and patient safety. Innovative features such as continuous flow centrifugation, closed-system processing, and real-time monitoring improve procedural efficiency, reduce operator variability, and minimize the risk of adverse events during apheresis procedures, driving the adoption of apheresis equipment in clinical practice.
- Expanding Applications in Therapeutic Plasma Exchange: Therapeutic plasma exchange (TPE) is increasingly utilized for the management of autoimmune disorders, neurologic diseases, and transplant-related complications. Apheresis equipment plays a crucial role in performing TPE procedures by selectively removing pathogenic antibodies, immune complexes, and toxic substances from the patient's plasma, contributing to disease remission and symptom relief in affected individuals.
Competitive Landscape:
The global Apheresis Equipment market features a competitive landscape with key players driving innovation and market expansion. The report profiles major companies, offering insights into their product portfolios, market share, strategic collaborations, and recent developments.
Challenges and Opportunities:
While the Apheresis Equipment Market presents significant opportunities, challenges such as high initial capital investment, reimbursement constraints, and regulatory compliance requirements need to be addressed. However, ongoing research, technological innovations, and the potential for market penetration in emerging economies offer avenues for growth and development in apheresis technology.
Table of Content
- INTRODUCTION
- Market Ecosystem
- Timeline Under Consideration
- Historical Years – 2020
- Base Year – 2021
- Forecast Years – 2022 to 2030
- Currency Used in the Report
- RESEARCH METHODOLOGY
- Research Approach
- Data Collection Methodology
- Data Sources
- Secondary Sources
- Primary Sources
- Market Estimation Approach
- Bottom Up
- Top Down
- Market Forecasting Model
- Limitations and Assumptions
- PREMIUM INSIGHTS
- Current Market Trends (COVID-19 Perspective)
- Key Players & Competitive Positioning (2021)
- MARKET DYNAMICS
- Drivers
- Restraints
- Opportunities
- GLOBAL APHERESIS EQUIPMENT MARKET- ANALYSIS & FORECAST, BY PRODUCT
- Devices
- Disposables
- GLOBAL APHERESIS EQUIPMENT MARKET- ANALYSIS & FORECAST, BY PROCEDURE
- Leukapheresis
- Plasmapheresis
- Plateletpheresis
- Erythrocytapheresis
- Photopheresis
- Others
- GLOBAL APHERESIS EQUIPMENT MARKET- ANALYSIS & FORECAST, BY TECHNOLOGY
- Centrifugation Apheresis
- Membrane Separation
- GLOBAL APHERESIS EQUIPMENT MARKET- ANALYSIS & FORECAST, BY APPLICATION
- Renal Disorders
- Hematological Disorders
- Neurological Disorders
- Autoimmune Disorders
- Others
Future Outlook:
The report provides a forward-looking perspective on the Single-Use Bioreactors market, offering insights into potential growth opportunities, emerging trends, and factors that could shape the market in the coming years. With a focus on enhancing bioprocessing efficiency, increasing manufacturing flexibility, and meeting evolving regulatory requirements, the global market is poised for continued expansion and innovation in single-use bioreactor solutions.
In conclusion, the report serves as a valuable resource for biopharmaceutical companies, contract manufacturers, investors, and other stakeholders, providing a comprehensive analysis of market trends, challenges, and opportunities. As single-use bioreactors continue to redefine biomanufacturing practices and drive the development of next-generation biopharmaceuticals, the Single-Use Bioreactors Market is poised to witness sustained growth and contribute to advancing healthcare worldwide.
VALUE PROPOSITIONS RELATED TO THE REPORT:
- Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
- Comprehensive quantitative and qualitative insights at segment and sub-segment level
- Covid 19 impact trends and perspective
- Granular insights at global/regional/country level
- Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
- Blanket coverage on competitive landscape
- Winning imperatives
- Exhaustive coverage on 'Strategic Developments' registered by leading players of the market
CUSTOMIZATION OPTIONS:
- Distributor Landscape Assessment
- Pricing Intelligence
- Customer Base Assessment
- Investment & Initiatives Analysis
- 'Business Profile' of Key Players
Buy this Premium Research Report: https://www.growthplusreports.com/checkout-8509
Browse other reports:
According to the deep-dive market assessment study by Growth Plus Reports, the global cell & tissue preservation market was valued at US$ 3.6 billion in 2022 and is expected to register a revenue CAGR of 12.2% to reach US$ 11.3 billion by 2031.
According to the deep-dive market assessment study by Growth Plus Reports, the global cloning and mutagenesis market was valued at US$ 2.45 billion in 2022 and is expected to register a revenue CAGR of 17.12% to reach US$ 10.15 billion by 2031.
According to the deep-dive market assessment study by Growth Plus Reports, the global healthcare chatbots market was valued at US$ 237 million in 2022 and is expected to register a revenue CAGR of 18.9% to reach US$ 949 million by 2031.
According to the deep-dive market assessment study by Growth Plus Reports, the global infant incubators market was valued at US$ 334.0 million in 2022 and is expected to register a revenue CAGR of 4.4% to reach US$ 471.0 million by 2031.
According to the deep-dive market assessment study by Growth Plus Reports, the global intra-compartmental pressure measuring systems market was valued at US$ 16.6 million in 2022 and is expected to register a revenue CAGR of 12.4% to reach US$ 47.6 million by 2031.
About Us:
Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).
Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.
We were awarded by the prestigious CEO Magazine as Most Innovative Healthcare Market Research Company in 2020.
